Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Dr. C H Weaver MD

  • FAQs: Molecular Residual Disease Testing in Colorectal Cancer
    February 27, 2026

    FAQs: Molecular Residual Disease Testing in Colorectal Cancer

    Dr. C H Weaver MD
  • Newly Diagnosed with Myelofibrosis: FAQs
    February 12, 2026

    Newly Diagnosed with Myelofibrosis: FAQs

    Dr. C H Weaver MD
  • Carbon Ion Therapy: A New Era in Precision Radiation
    February 9, 2026

    Carbon Ion Therapy: A New Era in Precision Radiation

    Dr. C H Weaver MD
  • New Study: Lifetime Alcohol Use and Colorectal Cancer Risk
    February 6, 2026

    New Study: Lifetime Alcohol Use and Colorectal Cancer Risk

    Dr. C H Weaver MD
  • Nutritious Recipes for Cancer Patients
    February 2, 2026

    Nutritious Recipes for Cancer Patients

    Dr. C H Weaver MD
  • February: Gallbladder and Bile Duct Awareness Month
    February 1, 2026

    February: Gallbladder and Bile Duct Awareness Month

    Dr. C H Weaver MD
  • New Latitude Blood Test Expands MRD Access Beyond Tumor Tissue–Dependent Options in Colorectal Cancer
    January 28, 2026

    New Latitude Blood Test Expands MRD Access Beyond Tumor Tissue–Dependent Options in Colorectal Cancer

    Dr. C H Weaver MD
  • Learn Look Locate + CancerConnect: How Dr. Charles Weaver Is Redefining Breast Cancer Navigation and Support
    January 27, 2026

    Learn Look Locate + CancerConnect: How Dr. Charles Weaver Is Redefining Breast Cancer Navigation and Support

    Dr. C H Weaver MD
  • New Option for BRCA2‑Positive Advanced Prostate Cancer
    January 14, 2026

    New Option for BRCA2‑Positive Advanced Prostate Cancer

    Dr. C H Weaver MD
  • FDA Approval of Liso-cel for Marginal Zone Lymphoma
    January 13, 2026

    FDA Approval of Liso-cel for Marginal Zone Lymphoma

    Dr. C H Weaver MD
  • Zanidatamab Combination May Become New First-Line Option for HER2-Positive Gastroesophageal Cancer
    January 13, 2026

    Zanidatamab Combination May Become New First-Line Option for HER2-Positive Gastroesophageal Cancer

    Dr. C H Weaver MD
  • Rucaparib (Rubraca) for Advanced Prostate Cancer
    January 12, 2026

    Rucaparib (Rubraca) for Advanced Prostate Cancer

    Dr. C H Weaver MD
Previous Page
1 2 3 4 5 6 … 383
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
Loading Comments...